Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 148Myelodysplastic Syndromes 116Leukemia 115Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Lymphoma 86Lymphoma, Non-Hodgkin 80Multiple Myeloma 74Hodgkin Disease 68Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Large B-Cell, Diffuse 52Myeloproliferative Disorders 51Congenital Abnormalities 51Leukemia, Myeloid, Chronic-Phase 50Lymphoma, Follicular 47Leukemia, Myeloid, Accelerated Phase 47Neoplasms, Plasma Cell 46Lymphoma, Mantle-Cell 43Leukemia, Myelomonocytic, Chronic 43Burkitt Lymphoma 42Lymphoma, B-Cell, Marginal Zone 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Blast Crisis 39Primary Myelofibrosis 36Recurrence 33Anemia, Refractory, with Excess of Blasts 33Hematologic Neoplasms 32Myelodysplastic-Myeloproliferative Diseases 31Graft vs Host Disease 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolism, Inborn Errors × Busulfan × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡